Obsidian Therapeutics opened higher at $12.99, compared with its previous close of $12.88. In the last trading session, the stock traded between $12.00 and $13.04. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 1 year ago in Obsidian Therapeutics is now worth
$ 100.00
Giving a profit of
$ 0.00 (0.00%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 2 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.40 (-3.09%)
Day High
$13.04
Day Low
$12.00
Day Open
$12.99
Prev Close
$12.88
Volume
2,80,526
1W Return
13.63%
1M Return
-2.33%
3M Return
-61.30%
6M Return
0.00%
1Y Return
0.00%
Fundamentals
Market Cap ($ Mn)
-
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-
ROCE
-
EPS (TTM)
-
Investment Returns
1 Week
13.63%
1 Month
-2.33%
3 Months
-61.30%
6 Months
0.00%
9 Months
0.00%
Financials
Quarterly
All values in $ Mn
0.0
Mar 25
0.0
Mar 26
Updates
6Nov
Obsidian reports 67% response rate for amsoki-cel in advanced melanoma
Amsoki-cel achieved a 67% objective response rate in advanced melanoma patients resistant to checkpoint inhibitors. Median progression-free survival was 8.3 months, with median duration of response not yet reached. Pooled safety data showed no ICANS, treatment-related mortality, or ICU transfers across 37 patients. 33% of patients remained in deep, ongoing response at 12 months post-infusion. Registration-enabling cohort topline data expected by year-end 2027.
6 days ago
2Oct
Obsidian Therapeutics to present amsoki-cel data at SITC 2026
Obsidian Therapeutics to present amsoki-cel data at SITC 2026. Pooled safety data from FIH and Phase 1/2 Agni-01 trials included. Efficacy update covers 15 patients at recommended phase 2 dose. Focus on immune-checkpoint inhibitor-resistant advanced melanoma.
